High variability of drug exposure: a biopharmaceutic risk factor for chronic rejection
- 1 August 1998
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (5), 1639-1641
- https://doi.org/10.1016/s0041-1345(98)00737-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- VARIABLE ORAL ABSORPTION OF CYCLOSPORINETransplantation, 1996
- THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1Transplantation, 1996
- REDUCED INTER- AND INTRASUBJECT VARIABILITY IN CYCLOSPORINE PHARMACOKINETICS IN RENAL TRANSPLANT RECIPIENTS TREATED WITH A MICROEMULSION FORMULATION IN CONJUNCTION WITH FASTING, LOW-FAT MEALS, OR HIGH-FAT MEALS1,2Transplantation, 1995
- Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationClinical Pharmacology & Therapeutics, 1993
- Michaelis-Menten kinetics determine cyclosporine steady-state concentrations: A population analysis in kidney transplant patientsClinical Pharmacology & Therapeutics, 1993
- THE ADVERSE IMPACT OF HIGH CYCLOSPORINETransplantation, 1993
- OPTIMIZATION OF CYCLOSPORINE THERAPY IN RENAL TRANSPLANTATION BY A PHARMACOKINETIC STRATEGYTransplantation, 1988
- Nifedipine: Kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administrationClinical Pharmacology & Therapeutics, 1986
- Routine Monitoring of Cyclosporine in Whole Blood and in Kidney Tissue Using High Performance Liquid ChromatographyJournal of Analytical Toxicology, 1986
- Dose‐dependent prednisolone kineticsClinical Pharmacology & Therapeutics, 1979